Purdue
Purdue Pharma headquarters; Victor J. Blue/Bloomberg via Getty Images (NEW YORK) — The company and once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June […]
-
Pages